| Michael Y Liu, MD | |
|
2450 Ashby Ave, Berkeley, CA 94705-2067 | |
| (510) 204-4444 | |
| Not Available |
| Full Name | Michael Y Liu |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 23 Years |
| Location | 2450 Ashby Ave, Berkeley, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467571091 | NPI | - | NPPES |
| 00A806660 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A80666 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pih Health Hospital-whittier | Whittier, CA | Hospital |
| Pih Hospital - Downey | Downey, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intercommunity Emergency Medical Group | 7911892534 | 38 |
News Archive
Decision Resources, Inc., forecasts that Amgen's novel biological agent for the treatment of osteoporosis, AMG-162, will become a blockbuster by 2013. Premium pricing of AMG-162 will propel the sales of this agent.
Caffeine is the most widely used psychoactive substance and is part of the daily diet of most people, whether they know it or not. Caffeine is being added to more products, including energy drinks and snack foods, with no regulations requiring the amount of caffeine to be included on the product label.
New cases of diabetes continue to increase as does the health burden for those with diabetes. Law is a critical tool for health improvement, yet assessments reported in a new study published in the American Journal of Preventive Medicine indicate that federal, state, and local laws give only partial support to guidelines and evidence-based interventions relevant to diabetes prevention and control.
One of the most controversial topics in neurology today is the prevalence of serious permanent brain damage after traumatic brain injury. Long-term studies and a search for genetic risk factors are required in order to predict an individual's risk for serious permanent brain damage, according to a review article published by Sam Gandy, MD, PhD, from the Icahn School of Medicine at Mount Sinai in a special issue of Nature Reviews Neurology dedicated to TBI.
Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free survival for patients with newly diagnosed, metastatic high-grade serous ovarian cancer, according to the results of the VELIA trial.
› Verified 6 days ago
| Entity Name | Intercommunity Emergency Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871535286 PECOS PAC ID: 7911892534 Enrollment ID: O20040708000780 |
News Archive
Decision Resources, Inc., forecasts that Amgen's novel biological agent for the treatment of osteoporosis, AMG-162, will become a blockbuster by 2013. Premium pricing of AMG-162 will propel the sales of this agent.
Caffeine is the most widely used psychoactive substance and is part of the daily diet of most people, whether they know it or not. Caffeine is being added to more products, including energy drinks and snack foods, with no regulations requiring the amount of caffeine to be included on the product label.
New cases of diabetes continue to increase as does the health burden for those with diabetes. Law is a critical tool for health improvement, yet assessments reported in a new study published in the American Journal of Preventive Medicine indicate that federal, state, and local laws give only partial support to guidelines and evidence-based interventions relevant to diabetes prevention and control.
One of the most controversial topics in neurology today is the prevalence of serious permanent brain damage after traumatic brain injury. Long-term studies and a search for genetic risk factors are required in order to predict an individual's risk for serious permanent brain damage, according to a review article published by Sam Gandy, MD, PhD, from the Icahn School of Medicine at Mount Sinai in a special issue of Nature Reviews Neurology dedicated to TBI.
Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free survival for patients with newly diagnosed, metastatic high-grade serous ovarian cancer, according to the results of the VELIA trial.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Y Liu, MD Po Box 12469, Westminster, CA 92685-2469 Ph: (866) 325-0282 | Michael Y Liu, MD 2450 Ashby Ave, Berkeley, CA 94705-2067 Ph: (510) 204-4444 |
News Archive
Decision Resources, Inc., forecasts that Amgen's novel biological agent for the treatment of osteoporosis, AMG-162, will become a blockbuster by 2013. Premium pricing of AMG-162 will propel the sales of this agent.
Caffeine is the most widely used psychoactive substance and is part of the daily diet of most people, whether they know it or not. Caffeine is being added to more products, including energy drinks and snack foods, with no regulations requiring the amount of caffeine to be included on the product label.
New cases of diabetes continue to increase as does the health burden for those with diabetes. Law is a critical tool for health improvement, yet assessments reported in a new study published in the American Journal of Preventive Medicine indicate that federal, state, and local laws give only partial support to guidelines and evidence-based interventions relevant to diabetes prevention and control.
One of the most controversial topics in neurology today is the prevalence of serious permanent brain damage after traumatic brain injury. Long-term studies and a search for genetic risk factors are required in order to predict an individual's risk for serious permanent brain damage, according to a review article published by Sam Gandy, MD, PhD, from the Icahn School of Medicine at Mount Sinai in a special issue of Nature Reviews Neurology dedicated to TBI.
Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free survival for patients with newly diagnosed, metastatic high-grade serous ovarian cancer, according to the results of the VELIA trial.
› Verified 6 days ago
Dr. Harold Saul Newman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1085 Sterling Ave, Berkeley, CA 94708 Phone: 510-845-7643 | |
Robert Michael Roth, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2450 Ashby Ave, Berkeley, CA 94705 Phone: 510-204-4723 | |
Dr. Mordechai Pavlovsky, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2450 Ashby Ave, Department Of Emergency Medicine, Berkeley, CA 94705 Phone: 925-962-1067 | |
Dr. Brian Richard Potts, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2450 Ashby Ave, Berkeley Emergency Medical Group, Berkeley, CA 94705 Phone: 925-962-1800 | |
Dr. Stephanie Yvonne Brown, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2450 Ashby Ave, Department Of Emergency Medicine, Berkeley, CA 94705 Phone: 510-204-4723 Fax: 510-204-4816 | |
Dr. Andrew Masaaki Osugi, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2450 Ashby Ave Ste 1160, Berkeley, CA 94705 Phone: 510-655-4000 | |
Joseph Daniel Pinizzotto, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2450 Ashby Ave, Berkeley, CA 94705 Phone: 215-456-3834 |